Paperpal Prime Logo

BMC Immunology : Impact Factor & More

eISSN: 1471-2172pISSN: 1471-2172
JournalOpen Access

Key Metrics

CiteScore
4.5
Eigenfactor
0.001 - 0.005
Impact Factor
< 5
SJR
Q3Immunology
SNIP
0.92
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on BMC Immunology

BMC Immunology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher BMC
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2390 | USD 2790 | GBP 1990
Publication Time21
Editorial Review ProcessOpen peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 21
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessOpen peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC0
OA statementVisit website
View less

Planning to publish in BMC Immunology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in BMC Immunology

Inflammatory responses in HIV-1 genetic subtypes in relationship with anti-retroviral drug resistance in Minna, Niger State, North Central Nigeria.
  • 29 Jun 2026
  • BMC immunology
Hsa_circ_0077658 serves as a potential diagnostic biomarker for severe pneumonia in children and alleviates lipopolysaccharide-induced damage to bronchial epithelial cells by modulating the miR-15a-5p/NF1 axis.
  • 24 Jun 2026
  • BMC immunology
Cytokine and chemokine signatures of steady-state sickle cell disease in African children: a cross-sectional study.
  • 24 Jun 2026
  • BMC immunology
Clinical and immunological factors associated with gastrointestinal involvement in common variable immunodeficiency: a real-world study.
  • 22 Jun 2026
  • BMC immunology
MicroRNA-18a-3p as a biomarker for neonatal respiratory distress syndrome and its effects in alveolar epithelial type II cells.
  • 18 Jun 2026
  • BMC immunology
The clinical significance of serum complement fibroblast growth factor 21 in patients with rheumatoid arthritis.
  • 15 Jun 2026
  • BMC immunology
Inflammatory responses in HIV-1 genetic subtypes in relationship with anti-retroviral drug resistance in Minna, Niger State, North Central Nigeria.
  • 29 Jun 2026
  • BMC immunology
Hsa_circ_0077658 serves as a potential diagnostic biomarker for severe pneumonia in children and alleviates lipopolysaccharide-induced damage to bronchial epithelial cells by modulating the miR-15a-5p/NF1 axis.
  • 24 Jun 2026
  • BMC immunology
Cytokine and chemokine signatures of steady-state sickle cell disease in African children: a cross-sectional study.
  • 24 Jun 2026
  • BMC immunology
Clinical and immunological factors associated with gastrointestinal involvement in common variable immunodeficiency: a real-world study.
  • 22 Jun 2026
  • BMC immunology
MicroRNA-18a-3p as a biomarker for neonatal respiratory distress syndrome and its effects in alveolar epithelial type II cells.
  • 18 Jun 2026
  • BMC immunology
The clinical significance of serum complement fibroblast growth factor 21 in patients with rheumatoid arthritis.
  • 15 Jun 2026
  • BMC immunology

FAQs on BMC Immunology